-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WXLg3jetQhq2YkNtXj35cmTGspzTSMRTsV+XELk3pMyiDr1HBlk7RiHgppajJ/LN hZ0UqwXpHR5wbEe1w8lXiA== 0001127602-10-006162.txt : 20100224 0001127602-10-006162.hdr.sgml : 20100224 20100224180953 ACCESSION NUMBER: 0001127602-10-006162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100222 FILED AS OF DATE: 20100224 DATE AS OF CHANGE: 20100224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graboyes Marc H CENTRAL INDEX KEY: 0001305811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29815 FILM NUMBER: 10630960 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001097264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541655029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 BUSINESS PHONE: 3034266262 MAIL ADDRESS: STREET 1: 11080 CIRCLEPOINT ROAD STREET 2: SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-02-22 0001097264 ALLOS THERAPEUTICS INC ALTH 0001305811 Graboyes Marc H 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 1 SVP, General Counsel Common Stock 2010-02-22 4 A 0 41617 0 A 61677 D Common Stock 2010-02-23 4 S 0 1416 7.51 D 60261 D Common Stock 2010-02-24 4 S 0 2349 7.44 D 57912 D Stock Options (Right to Buy) 7.56 2010-02-22 4 A 0 73083 7.56 A 2011-02-22 2020-02-22 Common Stock 73083 73083 D Represents shares of common stock subject to restricted stock units ("RSUs") awarded under the Company's 2008 Equity Incentive Plan (the "Plan"). The RSUs vest in a series of four (4) successive equal annual installments over the four (4)-year period measured from the Vesting Commencement Date, subject to Participant's Continuous Service through each such date. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Graboyes sold a portion of his holdings for tax and estate planning purposes. Stock options vest according to the following schedule: Twelve forty-eighths (12/48) of the total number of shares subject to this option shall vest twelve (12) months after the vesting commencement date and an additional one forty-eighths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable. /s/ David C. Clark, Attorney-in-Fact for Marc H. Graboyes 2010-02-24 -----END PRIVACY-ENHANCED MESSAGE-----